Diagam S.A.
BE-MF-000022993 · Belgium · Ghislenghien
Diagam S.A. is registered in the European database on medical devices as a manufacturer, with 959 devices declared. It is also registered as a device establishment with the U.S. FDA.
What this manufacturer declares
Devices declared under this manufacturer
- Albumin urine & CSF control H
- Albumin urine & CSF control M
- Alpha1-Acid Glycoprotein
- Alpha1-microglobulin
- Alpha2-macroglobulin
- Antistreptolysin O
- Beta2-microglobulin
- Beta2-microglobulin urine
- CRP XL Wide range
- Immunoglobulin G
- Lipoprotein (a)
- Retinol Binding Protein
Showing 12 of 959 declared devices.
Catalogue references include A1DGX-B00/COB, BUDGX-B00/ATE, CPTXL-L00/ATE, IGLCR-B00/COB, MACON-005, MGTUR-L00/ATE.
European nomenclature codes declared: W0102152003, W01021109, W0102039002, W0102010105, W0102010306, W0102010405.
United States market access
| FDA establishment register | Registered with FDA |
|---|---|
| Matched entry | DIAGAM S.A. (BE) · FDA 3003749380 |
| Devices in EUDAMED | 959 |
| Country of registration | Belgium |
Device-level evidence
| Devices with a numeric GTIN | 959 |
|---|---|
| Found in the U.S. device database | 4 |
| Share | 0.4 % |
Canadian market access
| Health Canada licence listing | Not found in the Canadian register |
|---|
⚠️ Canada lists no Class I devices at all — what that excludes.
North American profile: United States only. Diagam S.A. is registered in the United States but was not found in the Canadian register.